Bayer AG forecasts growth of its pharmaceutical business starting in 2027, an increase in operating margin to 30% by 2030, and plans to focus on five key therapeutic areas.
Bayer AG forecasts growth of its pharmaceutical business starting in 2027, an increase in operating margin to 30% by 2030, and plans to focus on five key therapeutic areas.
Залишити відповідь